1ztq

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1ztq" size="450" color="white" frame="true" align="right" spinBox="true" caption="1ztq, resolution 2.00&Aring;" /> '''Crystal structure o...)
Line 1: Line 1:
-
[[Image:1ztq.gif|left|200px]]<br />
+
[[Image:1ztq.gif|left|200px]]<br /><applet load="1ztq" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1ztq" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1ztq, resolution 2.00&Aring;" />
caption="1ztq, resolution 2.00&Aring;" />
'''Crystal structure of the catalytic domain of MMP-13 complexed with WAY-033'''<br />
'''Crystal structure of the catalytic domain of MMP-13 complexed with WAY-033'''<br />
==Overview==
==Overview==
-
A potent, selective series of MMP-13 inhibitors has been derived from a, weak (3.2 microM) inhibitor that did not bear a zinc chelator., Structure-based drug design strategies were employed to append a, Zn-chelating group to one end of the molecule and functionality to enhance, selectivity to the other. A compound from this series demonstrated rat, oral bioavailability and efficacy in a bovine articular cartilage explant, model.
+
A potent, selective series of MMP-13 inhibitors has been derived from a weak (3.2 microM) inhibitor that did not bear a zinc chelator. Structure-based drug design strategies were employed to append a Zn-chelating group to one end of the molecule and functionality to enhance selectivity to the other. A compound from this series demonstrated rat oral bioavailability and efficacy in a bovine articular cartilage explant model.
==About this Structure==
==About this Structure==
-
1ZTQ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with ZN, CA and 033 as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1ZTQ OCA].
+
1ZTQ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=CA:'>CA</scene> and <scene name='pdbligand=033:'>033</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1ZTQ OCA].
==Reference==
==Reference==
Line 18: Line 17:
[[Category: Geck, M.]]
[[Category: Geck, M.]]
[[Category: Hotchandani, R.]]
[[Category: Hotchandani, R.]]
-
[[Category: III, T.S.Rush.]]
+
[[Category: III, T S.Rush.]]
-
[[Category: Levin, J.I.]]
+
[[Category: Levin, J I.]]
[[Category: Lovering, F.]]
[[Category: Lovering, F.]]
[[Category: Skotnicki, J.]]
[[Category: Skotnicki, J.]]
[[Category: Wu, J.]]
[[Category: Wu, J.]]
-
[[Category: Xu, Z.B.]]
+
[[Category: Xu, Z B.]]
[[Category: 033]]
[[Category: 033]]
[[Category: CA]]
[[Category: CA]]
Line 37: Line 36:
[[Category: zinc chelator]]
[[Category: zinc chelator]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:41:23 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:18:58 2008''

Revision as of 14:19, 21 February 2008


1ztq, resolution 2.00Å

Drag the structure with the mouse to rotate

Crystal structure of the catalytic domain of MMP-13 complexed with WAY-033

Overview

A potent, selective series of MMP-13 inhibitors has been derived from a weak (3.2 microM) inhibitor that did not bear a zinc chelator. Structure-based drug design strategies were employed to append a Zn-chelating group to one end of the molecule and functionality to enhance selectivity to the other. A compound from this series demonstrated rat oral bioavailability and efficacy in a bovine articular cartilage explant model.

About this Structure

1ZTQ is a Single protein structure of sequence from Homo sapiens with , and as ligands. Full crystallographic information is available from OCA.

Reference

Identification of potent and selective MMP-13 inhibitors., Wu J, Rush TS 3rd, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE, Bioorg Med Chem Lett. 2005 Sep 15;15(18):4105-9. PMID:16005220

Page seeded by OCA on Thu Feb 21 16:18:58 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools